| 前收市價 | 1.2300 |
| 開市 | 1.2000 |
| 買盤 | 1.2200 x 2900 |
| 賣出價 | 1.2500 x 2700 |
| 今日波幅 | 1.2000 - 1.2415 |
| 52 週波幅 | 0.8500 - 2.2400 |
| 成交量 | |
| 平均成交量 | 9,424,382 |
| 市值 | 857.3M |
| Beta 值 (5 年，每月) | 1.84 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.2500 |
| 業績公佈日 | 2024年5月01日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.25 |
ZacksOPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.
- Zacks
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
ZacksOPKO Health (OPK) And Entera Bio Announce Data for GLP-2
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
